GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » Net-Net Working Capital

ADGM (Adagio Medical Holdings) Net-Net Working Capital : $-0.96 (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Adagio Medical Holdings's Net-Net Working Capital for the quarter that ended in Mar. 2025 was $-0.96.

The industry rank for Adagio Medical Holdings's Net-Net Working Capital or its related term are showing as below:

ADGM's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 6.78
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Adagio Medical Holdings Net-Net Working Capital Historical Data

The historical data trend for Adagio Medical Holdings's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings Net-Net Working Capital Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net-Net Working Capital
-5.60 -7.38 -10.14 -0.44

Adagio Medical Holdings Quarterly Data
Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only -10.14 -10.83 -0.02 -0.44 -0.96

Competitive Comparison of Adagio Medical Holdings's Net-Net Working Capital

For the Medical Devices subindustry, Adagio Medical Holdings's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adagio Medical Holdings's Price-to-Net-Net-Working-Capital Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's Price-to-Net-Net-Working-Capital falls into.


;
;

Adagio Medical Holdings Net-Net Working Capital Calculation

Adagio Medical Holdings's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net-Net Working Capital(A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(20.586+0.75 * 0.035+0.5 * 2.566-28.536
-0-0)/15.198
=-0.44

Adagio Medical Holdings's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2025 is calculated as

Net-Net Working Capital(Q: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(12.963+0.75 * 0.001+0.5 * 2.31-28.939
-0-0)/15.382
=-0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Adagio Medical Holdings  (NAS:ADGM) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Adagio Medical Holdings Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Adagio Medical Holdings's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Adagio Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.